These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

611 related items for PubMed ID: 16678055

  • 1. Proteomics for the identification of new prostate cancer biomarkers.
    Ornstein DK, Tyson DR.
    Urol Oncol; 2006; 24(3):231-6. PubMed ID: 16678055
    [Abstract] [Full Text] [Related]

  • 2. A data-analytic strategy for protein biomarker discovery: profiling of high-dimensional proteomic data for cancer detection.
    Yasui Y, Pepe M, Thompson ML, Adam BL, Wright GL, Qu Y, Potter JD, Winget M, Thornquist M, Feng Z.
    Biostatistics; 2003 Jul; 4(3):449-63. PubMed ID: 12925511
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Application of proteomic technologies for prostate cancer detection, prognosis, and tailored therapy.
    Fredolini C, Liotta LA, Petricoin EF.
    Crit Rev Clin Lab Sci; 2010 Jul; 47(3):125-38. PubMed ID: 20858067
    [Abstract] [Full Text] [Related]

  • 9. Proteomic analysis of conditioned media from the PC3, LNCaP, and 22Rv1 prostate cancer cell lines: discovery and validation of candidate prostate cancer biomarkers.
    Sardana G, Jung K, Stephan C, Diamandis EP.
    J Proteome Res; 2008 Aug; 7(8):3329-38. PubMed ID: 18578523
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Analysis of prostate cancer by proteomics using tissue specimens.
    Liu AY, Zhang H, Sorensen CM, Diamond DL.
    J Urol; 2005 Jan; 173(1):73-8. PubMed ID: 15592032
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Proteome analysis of prostate cancer.
    Kuruma H, Egawa S, Oh-Ishi M, Kodera Y, Maeda T.
    Prostate Cancer Prostatic Dis; 2005 Jan; 8(1):14-21. PubMed ID: 15477873
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Identification of lung cancer patients by serum protein profiling using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry.
    Han KQ, Huang G, Gao CF, Wang XL, Ma B, Sun LQ, Wei ZJ.
    Am J Clin Oncol; 2008 Apr; 31(2):133-9. PubMed ID: 18391596
    [Abstract] [Full Text] [Related]

  • 16. Profiling protein markers associated with lymph node metastasis in prostate cancer by DIGE-based proteomics analysis.
    Pang J, Liu WP, Liu XP, Li LY, Fang YQ, Sun QP, Liu SJ, Li MT, Su ZL, Gao X.
    J Proteome Res; 2010 Jan; 9(1):216-26. PubMed ID: 19894759
    [Abstract] [Full Text] [Related]

  • 17. Three new potential ovarian cancer biomarkers detected in human urine with equalizer bead technology.
    Petri AL, Simonsen AH, Yip TT, Hogdall E, Fung ET, Lundvall L, Hogdall C.
    Acta Obstet Gynecol Scand; 2009 Jan; 88(1):18-26. PubMed ID: 19023702
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Advanced proteomic technologies for cancer biomarker discovery.
    Wong SC, Chan CM, Ma BB, Lam MY, Choi GC, Au TC, Chan AS, Chan AT.
    Expert Rev Proteomics; 2009 Apr; 6(2):123-34. PubMed ID: 19385940
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.